Copyright
©The Author(s) 2019.
World J Gastrointest Surg. Dec 27, 2019; 11(12): 422-432
Published online Dec 27, 2019. doi: 10.4240/wjgs.v11.i12.422
Published online Dec 27, 2019. doi: 10.4240/wjgs.v11.i12.422
Figure 1 Design of the study protocol from the operation until second session of polymyxin B hemoperfusion.
PMX-HP: Polymyxin B hemoperfusion.
Figure 2 Outline of patient selection and propensity score matching.
PMX-HP: Polymyxin B hemoperfusion; APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; WBC: White blood cell; INR: International normalized ratio.
Figure 3 Comparison of the Sequential Organ Failure Assessment score at 72 h between polymyxin B hemoperfusion and control groups.
Error bars represent 95% confidence intervals. Negative values of delta Sequential Organ Failure Assessment scores indicate improvement of organ function. SOFA: Sequential Organ Failure Assessment; PMX: Polymyxin B.
- Citation: Kim JJ, Park YJ, Moon KY, Park JH, Jeong YK, Kim EY. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock. World J Gastrointest Surg 2019; 11(12): 422-432
- URL: https://www.wjgnet.com/1948-9366/full/v11/i12/422.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v11.i12.422